Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition

Clinical Nutrition

Volumn 21, Issue 4, 2002, Pages 337-343

  Luman, W ^a   Shaffer, J L ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

Complications; Home parenteral nutrition; Liver disease; Liver function tests

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; FAT; GLUCOSE; NITROGEN;

ADULT; AGED; ARTICLE; ENTEROPATHY; FEMALE; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PATHOLOGY; PREVALENCE; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; ALKALINE PHOSPHATASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CALORIC INTAKE; CONTROLLED STUDY; CROHN DISEASE; DIGESTIVE SYSTEM FISTULA; FOLLOW UP; HEPATOBILIARY PARAMETERS; HEREDITARY SPHEROCYTOSIS; HYPERBILIRUBINEMIA; INTESTINE ISCHEMIA; LIVER DYSFUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NUTRITIONAL REQUIREMENT; PERITONEUM ADHESION; PROGNOSIS; REFERENCE VALUE; RISK FACTOR;

ADULT; AGED; ALKALINE PHOSPHATASE; FEMALE; HUMANS; INTESTINAL DISEASES; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PARENTERAL NUTRITION, HOME; PREVALENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036022719     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.2002.0554     Document Type: Article

References (31)

1. Home parenteral nutrition in adults: A European multicentre survey in 1997
2. The role of home parenteral nutrition in the management of intestinal failure-report of 400 cases
3. Quality of life in patients receiving home parenteral nutrition
4. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure
5. Liver dysfunction associated with long term total parenteral nutrition in patients with massive bowel resection
6. Hepatobiliary complications of total parenteral nutrition
7. Liver function tests in patients receiving parenteral nutrition
8. Food intake of adults with intestinal failure on home parenteral nutrition
9. Long term total parenteral nutrition with growth, development, and positive nitrogen balance
10. Prevention of liver failure in parenteral-nutrition dependent children with short bowel syndrome
11. Hepatobiliary complications of long-term home parenteral nutrition
12. Liver complications of pediatric parenteral nutrition-epidemiology
13. Does long term home parenteral nutrition in adult patients cause chronic liver disease
14. Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition
15. Metronidazole prevention of serum liver enzyme abormalities during total parenteral nutrition
16. Bile acids, liver injuury and liver disease
17. The role of endotoxins in liver injury
18. Hepatic steatosis after intestinal bypass-prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition
19. Hepatic alterations during total parenteral nutrition in patients with inflammatory bowel disease: A possible consequence of lithocholate toxicity
20. Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition
21. Prospective controlled study of parenteral nutrition-associated cholestatic jaundice
22. Hyperbilirubinaemia in neonates associated with total parenteral nutrition
23. The effect of hyperalimentation-hepatic lipid content and lipogenic enzyme activity in rats and man
24. Hepatic complications of total parenteral nutrition
25. Total parenteral nutrition associated cholestasis: Clinical and histopatologic correlation
26. Abnormal liver function during parenteral nutrition: Relation to infusion of excess
27. Metabolic consequences of hypercaloric glucose infusions
28. Similar liver function abnormalities occur in patients receiving glucose-based and lipid based parenteral nutrition
29. Infusion of long-chain or medium-chain triglycerides inhibits peripheral glucose metabolism in men
30. Changes of hepatic morphology during parenteral nutrition with lipid emulsions containing LCT or MCT/LCT quantified by ultrasound scan